Patent details
EP3222278 Title: USE OF AZELNIDIPINE IN PREPARING MEDICINAL COMPOSITION FOR TREATING CANCERS
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 21/06/2023
- Unitary Effect Status:
- Unitary Effect Registered
- Request Unitary Effect Accepted:
- 12/07/2023
- Unitary Effect Date:
- 14/06/2023
- Unitary Effect Registration Date:
- 12/07/2023
- Request Unitary Effect Rejected:
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Unitary Effect Request Withdrawal Date:
- Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
- UPP register:
- EP3222278
- SPC Number:
- Creation Date:
Basic Information
- Publication number:
- EP3222278
- WO Application Number:
- CN2015092714
- Type:
- European Patent Granted for NL
- Status:
- Unitary Effect Registered
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP15852781.2
- WO Publication Number:
- WO2016062275
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- Taiwan, Chinese Taipei (TW)
- Publications:
Dates
- Filing date:
- 23/10/2015
- Grant date:
- 14/06/2023
- EP Publication Date:
- 27/09/2017
- WO Publication Date:
- 28/04/2016
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 14/06/2023
- EP B1 Publication Date:
- 14/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 22/10/2035
- Lapsed By Expiration Date:
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 14/06/2023
- Name:
- Launx Biomedical Co., Ltd.
- Address:
- 2F. No.1 Ln. 32 Ziqiang 1st Rd. Qianjin Dist., Kaohsiung City 801, Taiwan, Chinese Taipei (TW)
Inventor
1
- Name:
- CHEN, Chiu-Hung
- Address:
- Kaohsiung City 801, Taiwan, Chinese Taipei (TW)
2
- Name:
- CHUANG, Show-Mei
- Address:
- Taichung City 408, Taiwan, Chinese Taipei (TW)
3
- Name:
- WAY, Tzong-Der
- Address:
- Kaohsiung City 801, Taiwan, Chinese Taipei (TW)
4
- Name:
- HSIAO, Nai-Wan
- Address:
- Taichung City 402, Taiwan, Chinese Taipei (TW)
Priority
- Priority Patent Number:
- 201462068298 P
- Priority Date:
- 24/10/2014
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 31/4422; A61P 35/00; A61P 35/04;
Publication
Bulletin
1
- Bulletin Heading:
- UP1
- Journal edition number:
- 33/23
- Publication date:
- 16/08/2023
- Description:
- European patents with registered Unitary Effect
2
- Bulletin Heading:
- EP2
- Journal edition number:
- 24/23
- Publication date:
- 14/06/2023
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
1
- Issue number:
- 202333
- Publication date:
- 16/08/2023
- Description:
- Unitary Effect Request Acceptance
2
- Issue number:
- 202330
- Publication date:
- 26/07/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202324
- Publication date:
- 14/06/2023
- Description:
- Grant (B1)
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Document Description | Number of pages | File Type |
|---|